Glyoxalase: Difference between revisions
Michal Harel (talk | contribs) New page: == Your Heading Here (maybe something like 'Structure') == <StructureSection load='1dq8' size='350' side='right' caption='Structure of HMG-CoA reductase (PDB entry 1dq8)' scene=''> Any... |
Michal Harel (talk | contribs) No edit summary |
||
(21 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
<StructureSection load='' size='350' side='right' scene='50/508460/Cv/1' caption='Human glyoxalase I dimer complex with glutathione derivative and Zn+2 ion (grey) [[1qin]]'> | |||
<StructureSection load=' | |||
== Function == | |||
'''Glyoxalase''' (GLO) is part of glyoxalase system which | '''Glyoxalase''' (GLO) is part of the glyoxalase system which detoxifies the highly toxic methylglyoxal and other aldehydes produced by metabolism<ref>PMID:10066594</ref>. <br /> | ||
* '''GLO1''' or '''lactoylglutathione lyase''' catalyzes the conversion of glutathione and methylglyoxal to lactoylglutathione.<br /> | |||
* '''GLO2''' is a metalloenzyme which catalyzes the hydrolysis of lactoylglutathione to glutathione and lactate. GLO2 exists as cytosolic and mitochondrial forms. For details on GLO2 see [[Leishmania infantum Glyoxalase II]]. | |||
== | == Relevance == | ||
GLO1 is a target for drugs against bacteria, protozoans and cancer<ref>PMID:8277832</ref>. The GLO system is a focus of research on metabolic control and prevention of vascular complications in diabetes and obesity<ref>PMID:21335095</ref>. | |||
== Structural highlights == | |||
= | <scene name='50/508460/Cv/5'>Human GLO1 active site contains Zn+2 atom</scene><ref>PMID:10521255</ref>. Water molecules are shown as red spheres. | ||
[[ | ==3D structures of glyoxalase== | ||
[[Glyoxalase 3D structures]] | |||
</StructureSection> | |||
[[ | |||
== References == | |||
<references/> | |||
[[Category:Topic Page]] |